Preview

Antibiot Khimioter = Antibiotics and Chemotherapy

Advanced search

Study of the Pharmacokinetics and Safety of Dioxidine®, Solution for Topical and External Use, 0.25 mg/ml, in Various Routes of Administration

https://doi.org/10.37489/0235-2990-2023-68-11-12-30-37

Abstract

Topical use of antibacterial drugs as part of complex therapy for purulent-inflammatory infections of the skin and oropharynx can not only eliminate the symptoms but also influence the cause of the disease. Dioxidine® is a broad-spectrum antibacterial drug, active against both gram-positive and gram-negative bacteria. The aim of this study was to investigate the bioavailability, pharmacokinetic parameters, and safety profile of Dioxidine®, solution for topical and external use, 0.25 mg/ml, in cutaneous and topical application. Another dosage form of Dioxidine® — a solution for infusion and external use, 5 mg/ml — was used as a comparison drug. The study consisted of 4 stages reflecting different routes of drug administration: rinsing the oropharynx (path A), a single irrigation of the oropharynx using a spray nozzle (path B), back skin irrigation (path C), and intravenous administration (path D — for the reference drug). The results of the study made it possible to determine the absolute dose-normalized bioavailability of the study drug in the indicated routes of administration, as well as to evaluate its safety profile.

About the Authors

V. A. Stepanov
X7 Clinical Research, LLC
Russian Federation

Vadim A. Stepanov — Senior physician

Saint-Petersburg



S. V. Ponasenkova
X7 Clinical Research, LLC
Russian Federation

Svetlana V. Ponasenkova — Head of the Phase 1 and Bioequivalence Department

Saint-Petersburg



E. S. Simonova
X7 Clinical Research, LLC
Russian Federation

Evgenia S. Simonova — Physician

Saint-Petersburg



P. D. Sobolev
Exacte Labs, LLC
Russian Federation

Pavel D. Sobolev — Head of the Bioanalytical Laboratory

Moscow



A. G. Nikiforova
Exacte Labs, LLC
Russian Federation

Aiyyna G. Nikiforova — Head of the Bioanalytical Department

Moscow



A. A. Globenko
Valenta Pharm JSC
Russian Federation

Alexander A. Globenko — Head of the Medical Department

Moscow



A. V. Kapashin
Valenta Pharm JSC
Russian Federation

Aleksey V. Kapashin — Head of the Group for Development and Analysis of the Clinical Trial Documents and Registration Dossiers

Moscow



M. A. Pasko
Valenta Pharm JSC
Russian Federation

Maksim A. Pasko — Ph. D. in Medicine, Specialist of the Group for Development and Analysis of the Clinical Trial Documents and Registration Dossiers

Moscow



References

1. Norton L., Myers A. The treatment of streptococcal tonsillitis/ pharyngitis in young children. World Journal of Otorhinolaryngology. Head and Neck Surgery. 2021; 07 (03): 161–165. doi: 10.1016/j.wjorl.2021.05.005.

2. Sadeghirad B., Siemieniuk R.A.C., Brignardello-Petersen R., Papola D., Lytvyn L., Vandvik P.O., Merglen A., Guyatt G.H., Agoritsas T. Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials. BMJ. 2017; 358: j3887. doi: 10.1136/bmj.j3887.

3. Morozova S.V. Reasonableness of symptomatic therapy of acute tonsillopharyngitis. RMJ. 2013; 29: 1496. (in Russian)

4. Karpischenko S.A., Kolesnikova O.M. Topical therapy of acute tonsillopharyngitis. RMJ. 2022; 2: 50–54. (in Russian)

5. Zakharova I.N., Berezhnaya I.V., Maykova I.D. et al. Acute tonsillopharyngitis of streptococcal etiology in children: the importance of rapid diagnosis. RMJ. 2023; 2: 67–71. (in Russian)

6. Ostryj tonzillit i faringit (ostryj tonzillofaringit). Klinicheskie rekomendatsii (odobreno Nauchno-prakticheskim Sovetom Minzdrava RF). 2021. (in Russian)

7. Masyukova S.A, Glad'ko V.V, Ustinov M.V. et al. Bakterial'nye infektsii kozhi i ikh znachenie v klinicheskoy praktike dermatologa. Consilium Medicum. 2004; 6 (3): 180–185. (in Russian)

8. Belkova Yu.A. Pyoderma in Outpatients. Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7 (3): 255–270. (in Russian)

9. Olisova O.Yu., Plieva L.R. Therapy of pyoderma. RMJ. 2014; 8: 610–612. (in Russian)

10. Plieva L.R. On therapy of surface pyoderma. Rossiyskiy Zhurnal Kozhnykh i Venericheskikh Bolezney. 2015; 18 (1): 37–39. (in Russian)

11. Piodermii. Klinicheskie rekomendatsii (razrabotany Obshcherossijskoj obshchestvennoj organizatsiej «Rossijskoe Obshchestvo Dermatovenerologov i Kosmetologov). 2020. (in Russian)

12. Kryukov A. I., Kunelskaya N. L., Tsarapkin G. Y. et al. A study of the efficacy and safety of local antibiotic treatment of acute purulent maxillary sinusitis. Meditsinskiy Sovet. 2015; 15: 12–9. (in Russian)

13. Svistushkin V.M., Nikiforova G.N., Shevchik E.V., Zolotova A.V., Volkova K.B. Possibilities of topical etiotropic therapy of chronic tonsillitis patients. Meditsinskiy Sovet. 2016; 18: 116–120. https://doi.org/10.21518/2079-701X-2016-18116-120. (in Russian)

14. Kryukov A.I., Kunelskaya N.L., Gurov A.V., Izotova G.N., Romanenko S.G., Pavlikhin O.G., Muratov D.L. Prospects for antiseptics in the treatment of laryngeal and tonsillar pathology. Meditsinskiy Sovet. 2016; 6: 36-40. https://doi.org/10.21518/2079-701X-2016-6-36-40. (in Russian)

15. Ovchinnikov A. Yu., Egiyan S. S. Etiotropic treatment of inflammatory diseases of the external and middle ear. Rossiiskaya Otorinolaringologiya. 2021; 20 (6): 115–124. https://doi.org/10. 18692/1810-48002021-6-115-124. (in Russian)

16. Ryabova M.A., Ulupov M.Yu. Treatment of chronic rhinosinusitis exacerbations. Meditsinskiy Sovet. 2022; 16 (8): 56–60. https://doi.org/10.21518/2079-701X2022-16-8-56-60. (in Russian)

17. Ryazantsev S.V., Balatskaya K.A., Tkachuk I.V., Golovanov A.E., Kireev P.V. Topical antibiotic therapy for perforated otitis in the COVID-19 pandemic. Meditsinskiy Sovet. 2022; 16 (20): 101–109. https://doi.org/10.21518/2079701X-2022-16-20-101-109. (in Russian)

18. Belousova T.A., Paramonov A.A., Goryachkina M.V. Local therapy of bacterial and necrotic ulcerative lesions of the skin and soft tissues: search for optimal solutions. Farmateka. 2014; 10: 62. (in Russian)

19. Kashnikov V.N., Mikhailova T.L., Golovenko O.V. et al. Severe generalized form of gangrenous pyoderma in a patient with ulcerative colitis (clinical observation). Koloproktologia. 2011; 1 (35): 37–40. (in Russian)

20. Bogdanets L.I.,Smirnova E.S., Vasiliev I.M. Effectiveness of Dioxidine in the treatment of trophic ulcers of venous etiology. Pirogov Russian Journal of Surgery. 2014; 9: 64–67. (In Russian)


Review

For citations:


Stepanov V.A., Ponasenkova S.V., Simonova E.S., Sobolev P.D., Nikiforova A.G., Globenko A.A., Kapashin A.V., Pasko M.A. Study of the Pharmacokinetics and Safety of Dioxidine®, Solution for Topical and External Use, 0.25 mg/ml, in Various Routes of Administration. Antibiot Khimioter = Antibiotics and Chemotherapy. 2023;68(11-12):30-37. (In Russ.) https://doi.org/10.37489/0235-2990-2023-68-11-12-30-37

Views: 330


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 0235-2990 (Print)